As for clinical practice, since bone histomorphometry is invasive, expensive, and not widely available, our results suggest exploiting bone biomarkers, such as PTH, BSAP, and P1NP, can help identify bone turnover in HD patients. The gene discussed is PTH; the disease is Huntington disease.